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I n t r o d u c t i o n.  Bone is the most common site of cancer dissemination and 70% of patients with bone lesions present with
pain requiring therapy. Radiotherapy plays a major role in the treatment of painful bone metastases, but optimal dose and
fractionation regime remain debatable.
M a t e r i a l  a n d  m e t h o d s.  To address this issue a randomized trial comparing a single dose of 8 Gy vs. 20 Gy in 5 fractions
was performed and enrolled 115 patients with 146 metastatic lesions. Pain relief was assessed longitudinally based on a pain
questionnaire, in which patients were supposed to record their pain intensity using a 4-point scale (none, mild, moderate,
severe), as well as doses and types of analgesic drugs taken. Questionnaires were collected prior to treatment, 2, 4 and 8 weeks
after treatment completion and every 4 weeks thereafter.
Re s u l t s.  Complete pain relief was achieved in 23 patients (36%) treated with one fraction of 8 Gy and in 24 patients (39%)
who received 20 Gy in 5 fractions (p=0.96). Remarkable pain relief after one fraction and 5 fractions was achieved in 21
patients (33%) and 18 patients (29%), respectively (p=0.89) and moderate pain relief in 9 patients (14%) and 10 patients
(16%), respectively (p=0.94). There was also no difference between the two treatment regimes according to duration of pain
relief (medians of 8 and 10 months, respectively).
C o n c l u s i o n s.  Single fraction of 8 Gy is equally effective to a fractionated schedule in the treatment of painful bone
metastases, and should be recommended as standard care in the majority of patients.
20 Gy w pi´ciu frakcjach w porównaniu z 8 Gy w jednej frakcji w paliatywnej radioterapii przerzutów do koÊci
– wielooÊrodkowe badanie randomizowane
U z a s a d n i e n i e.  KoÊci stanowià najcz´stszà lokalizacj´ przerzutów nowotworów z∏oÊliwych, a w 70% przypadków zmianom
tym towarzyszà dolegliwoÊci bólowe, wymagajàce leczenia. Radioterapia odgrywa istotnà rol´ w leczeniu bolesnych przerzu-
tów do koÊci, ale optymalna dawka i sposób frakcjonowania sà nadal przedmiotem dyskusji.
M a t e r i a ∏  i m e t o d y.  Celem oceny skutecznoÊci leczenia jednorazowà dawkà 8 Gy przeprowadzono wielooÊrodkowe ba-
danie randomizowane, w którym porównywano efekt paliatywny napromieniania jednorazowà dawkà 8 Gy i dawkà 20 Gy w 5
frakcjach. Do badania w∏àczono 115 chorych, u których poddano napromienianiu ∏àcznie 146 ognisk przerzutowych. Nasi-
lenie bólu oceniane by∏o na podstawie kwestionariusza wype∏nianego przez chorego przed leczeniem oraz w 2, 4 i 8 tygodniu
po leczeniu, a nast´pnie co 4 tygodnie.
W y n i k i.  Ca∏kowite ustàpienie bólu osiàgni´to u 23 chorych (36%) leczonych jednà frakcjà i u 24 (39%) leczonych dawkà
20 Gy w 5 frakcjach (p=0,96). Znaczne ustàpienie dolegliwoÊci bólowych przy u˝yciu jednej frakcji i 5 frakcji osiàgni´to od-
powiednio u 21 chorych (33%) i 18 chorych (29%; p=0,89), a cz´Êciowe – odpowiednio u 9 chorych (14%) i 10 chorych
(16%) (p=0,94). Czas utrzymywania si´ efektu przeciwbólowego by∏ podobny w porównywanych grupach (mediany odpowied-
nio 8 i 10 miesi´cy).
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Introduction
Bone is the most common site of cancer dissemination
and 80% of patients dying with cancer have bone
metastases [1]. Up to 70% of patients with bone lesions
suffer from pain requiring therapy. External beam
radiotherapy plays a major role in the treatment of painful
bone metastases, but the optimal dose schedule remains
a matter of debate. A series of randomized trials has
evaluated pain relief in patients irradiated with a single 8
Gy fraction or with fractionated schedules and no
significant differences were found [2-4]. Although these
publications have suggested that a single fraction of
radiotherapy is more cost-effective and as good as
fractionated schedules in terms of pain relief, many
radiation oncologists still use multiple fractions. This
is probably a result of tradition, past teaching and
reimbursement criteria [5]. This study was performed in
order to confirm previous results and to convince
radiation oncologists in Poland to more frequent use of
single-fraction irradiation.
Pa t i e n t s  a n d  m e t h o d s
A total of 115 patients from five radiation oncology centers in
Poland were enrolled in the study over 4 years. Altogether 146
metastatic lesions diagnosed in these patients were randomized
to receive either 20 Gy in 5 fractions or 8 Gy in one fraction.
Because randomization included metastatic sites, patients with
more then one metastatic lesion might have been irradiated
with 8 Gy in one fraction to one site and 20 Gy in five fractions
to the other.
Inclusion criteria covered cytological or histopathological
evidence of malignant disease, painful bone metastases
confirmed by x-ray, and patient compliance. Patients with
pathological fracture or previous irradiation to the metastatic
sites were excluded. Randomization was performed by
a dedicated computer program after telephone contact with the
coordinating center. Data was stratified based on the type of
malignancy, site of metastatic bone lesion and type of equipment
used for irradiation.
Choice of radiotherapy technique was left to discretion of
the treating physician; both single-field and two parallel-opposed
field techniques were allowed. For single-field irradiation, the
dose was specified on the lesion depth, whereas for parallel-
opposed fields the dose was specified in the mid-plane. No
restrictions were made for machine or photon energy used for
irradiation. A majority of the patients were treated with
orthovaltage units (63%), some with cobalt units (31%) and
very few with linear accelerators (5%). The single-field technique
was used more frequently (76%), than the two parallel-opposed
fields technique (24%).
Pain relief was assessed basing on a pain questionnaire,
in which patients were requested to record their pain intensity
using a 4-point scale (none, mild, moderate, severe), as well as
doses and types of analgesic drugs taken. Patients were asked to
complete the questionnaire immediately before treatment, 2,
4, 8 weeks after the irradiation and every 4 weeks thereafter. An
additional questionnaire was completed by the treating physician
at each follow-up visit. Pain relief was defined as a decrease in
pain score recorded by the patient, by at least one category, or
significant decrease in doses of analgesic drugs taken with stable
pain level. Complete response was defined as complete
disappearance of pain and withdrawal of all analgesic drugs
taken by the patient.
In order to compare categorical data we used the
Chisquared test and Fisher’s exact test. Response duration
time distribution was assessed according to the Kaplan-Meier
method, for comparisons between subgroups we used the 
log-rank test.
Results
We included 115 patients in whom 146 metastatic bone
lesions were treated. The most common localization of
metastatic sites was the spine, followed by the pelvis,
limbs and ribs. The most frequent primary tumor was
breast cancer, followed by kidney, lung and prostate
cancers. A total of 74 metastatic lesions were randomized
to receive 20 Gy in 5 fractions and 72 – to 8 Gy in one
fraction. Both groups were well balanced in regard to
age, sex, performance status, primary tumor location,
metastatic site location and treatment technique used
(Tables I and II).
Table I. Patient characteristics
Variable 20 Gy/5 fr. 8 Gy/1 fr.
Age
range 33-78 23-80
mean 57.6 55.7
Sex
male 18 (31%) 16 (28%)
female 40 (69%) 41 (72%)
PS
0 9 (16%) 9 (16%)
1 15 (26%) 18 (32%)
2 26 (44%) 21 (37%)
3 4 (7%) 7 (12%)
Primary tumor
Breast 28 (48%) 28 (49%)
Kidney 4 (7%) 6 (11%)
Lung 6 (10%) 8 (14%)
Prostate 4 (7%) 3 (5%)
Other 16 (28%) 12 (21%)
W n i o s k i.  Efekt przeciwbólowy napromieniania pojedynczà dawkà 8 Gy i wy˝szà dawkà podanà w kilku frakcjach jest
podobny. Napromienianie jednà frakcjà mo˝e byç zatem zalecane u wi´kszoÊci chorych.
Key words: bone metastases, palliative radiotherapy, single fraction irradiation, randomized study
S∏owa kluczowe: przerzuty do koÊci, paliatywna radioterapia, napromienianie pojedyƒczà frakcjà, 
badanie randomizowane
263
Table II. Treatment charcteristics
Characteristics 20 Gy/5 fr. 8 Gy/1 fr.
Unit
Orthovoltage 37 (64%) 36 (63%)
60Co 20 (34%) 16 (28%)
Linear accelerator 1 (2%) 5 (9%)
Technique
Single-field technique 42 (78%) 42 (76%)
Two parallel opposed fields 12 (22%) 13 (24%)
Response to treatment was assessed in 104 patients
in whom 126 metastatic lesions were treated. The
remaining 11 patients were lost to follow up or died
before the first assessment. Of those 126 lesions, 64 were
randomized to receive 8 Gy in one fraction and 62 to
receive 20 Gy in 5 fractions. Complete pain relief was
achieved in 23 patients (36%) treated with one 8 Gy
fraction and in 24 patients (39%) who received 20 Gy in 5
fractions (p=0.96). Remarkable pain relief was achieved
in 21 patients (33%) and 18 patients (29%; p=0.89) and
moderate pain relief in 9 patients (14%) and 10 patients
(16%), respectively (p=0.94). In 11 (17%) and 10 patients
(16%), respectively, no pain relief was achieved (p=0.92;
Table III). No significant difference in the response rates
was seen among tumors of different histopathology.
Table III. Response to treatment
Response 20 Gy/5 fr. 8 Gy/1fr.
Complete relief 24 (39%) 23 (36%)
Remarkable relief 18 (29%) 21 (33%)
Moderate relief 10 (16%) 9 (14%)
No effect 10 (16%) 11 (17%)
p=0.956
Response duration was similar in patients treated
with 1 fraction and 5 fractions (medians of 8 months and
10 months, respectively; p=0.93) (Figure 1). In patients
who achieved complete pain relief the median time to
pain reappearance with 1 fraction and 5 fractions was
10 months and 11 months, respectively (p=0.87). In
patients with remarkable improvement median duration
of pain relief was 8 months and 7.5 months, respectively
(p=0.64).
Discussion
This study did not demonstrate any difference between
treatment effects achieved by palliative irradiation with 8
Gy in 1 fraction and 20 Gy in 5 fractions. The percentage
of patients with complete, remarkable and moderate pain
relief, as well as the duration of pain relief were not
significantly different in both the study arms. Similar
results were demonstrated in other randomized studies
comparing single fraction of 8 Gy with various fractio-
nation schedules [3, 4, 6, 7], although in one study the
retreatment rate was somewhat higher in patients who
had received a single fraction of 8 Gy [7]. In the light of
similar efficacy of both methods in terms of pain control
and relief duration, the higher retreatment rate in patients
receiving single fraction can probably be explained by
physicians’ preferences.
The largest trial comparing treatment effects of
different radiotherapy schedules in palliation of bone
metastases was performed by the Radiation Therapy
Oncology Group [2]. A total of 759 metastatic sites were
evaluated for pain relief produced by the 5 different
fractionated schedules: 40 Gy in 15 fractions, 20 Gy in
5 fractions, 30 Gy in 3 fractions, 27 Gy in 5 fractions and
25 Gy in 5 fractions. None of the regimens was
significantly superior over the others in terms of response
rates and pain relief duration. Subsequent reanalysis of
this data with different statistical methods and different
endpoints found relationship between higher doses in
more fractions and improved pain control [8]. This
reanalysis was criticized on methodological grounds and
because the authors did not use original data from the
RTOG study (which were lost) [9-11]. The factor which
may considerably influence results is the endpoint
definition chosen in particular studies. By combining pain
score, analgesic drugs taken by patient and retreatment
rate in various ways, different conclusions could be drawn
in the course of the same study. For this reason, despite
published results of randomized studies, the optimal
treatment regime for palliation of painful bone metastases
still remains debatable. A recent consensus meeting
on the palliative radiotherapy endpoints developed
guidelines for the future studies to ensure consistency of
reporting [12].
Doses lower then 8 Gy were investigated in some
studies. One trial compared a single fraction treatment
using 4 Gy and 8 Gy and found asignificantly better effect
in patients treated with higher doses (pain relief rate for
8 Gy and 4 Gy was 69% and 44%, respectively; p<0.001)
[13]. Another study comparing 3 single fraction doses:
8 Gy, 6 Gy and 4 Gy demonstrated similar results for the
two former regimes, whereas the dose of 4 Gy was
significantly less effective [14]. Thus, doses lower than
8 Gy should only be used in case of reduced tolerance.
Analogous to the results published by other authors
[2, 13], in the present study no significant difference inFirure 1. Pain relief duration
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treatment effect was found between primary tumors
of different types. These findings suggest that tumor
regression is not necessary for pain reduction, as treat-
ment effects are similar in radioresistant and radio-
sensitive tumors. The palliative effect of irradiation for
bone metastases probably results from killing the
radiosensitive cells – macrophages secreting various
cytokines and osteoclasts responsible for bone destruc-
tion. The levels of osteoclast activity markers were shown
to stabilize after the irradiation for bone metastases and
raise in not irradiated patients [15]. In patients with
a single metastatic lesion and relatively good prognosis
recalcification of osteolytic lesions may be another goal of
treatment. In such cases higher doses may be needed for
cell killing sufficient for recalcification and bone
stabilization [16].
In conclusion, our results indicate that single-fraction
irradiation of 8 Gy is as effective as a fractionated
schedule in the treatment of painful bone metastases.
Further carefully designed studies may be needed to
optimize radiotherapy delivery in particular categories
of patients and to find most effective means of combining
radiotherapy with other treatments of bone metastases.
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